A decision on May 10 by an FDA advisory panel to support the use of the drug Truvada to prevent HIV in certain high-risk populations is causing concern among many medical professionals who treat HIV patients. Truvada is already used for treatment of HIV. The action marks the first time that the panel has supported the use of an antiretroviral drug Read more
≡ Content Category
≡ Main Menu
Don't Miss a Dose of
The Doctor's Tablet!
Popular Posts
- First-Year Medical Student: Aftershocks
- Ph.D. Orientation: Exploring the Field
- After Affirmative Action: Safeguarding Progress and Supporting DEI in Academic Medical Centers
- Long COVID Is a Mass Disabling Condition—Treat It Like One
- Bittersweet Butterfly: Bidding Goodbye to Bench Science
- Med School Graduation—the Final Exam
- The Health Consequences of Underdiagnosed PTSD
- Supporting Parents of Children with Developmental Disabilities on Their Unexpected Journey
Search the Tablet
Categories
#MedMo Aging Autism Bioethics biomedical research Cancer CERC COVID-19 Diabetes Diet diversity doctor-patient relations Education Genetics global health infectious disease match day medical education Medical School medical students nutrition Obesity Pediatrics pregnancy public health Research Social Media Women's Health
Archives
